Magazine Article | March 31, 2015

What Big Pharma Can Do To Combat The Latest Patent Cliff

Source: Life Science Leader

The patent cliff era is far from over for the pharma industry. In the last three years, some of the biggest drugmakers have seen their blockbuster patents expire, a trend that will only increase going forward. A recent study by GlobalData estimates the industry will lose more than $60 billion in revenue through the end of 2019 due to the patent cliff.